Association of PLA2G4A with myocardial infarction is modulated by dietary PUFAs

American Journal of Clinical Nutrition

Volumn 95, Issue 4, 2012, Pages 959-965

  Hartiala, Jaana ^a   Gilliam, Elizabeth ^a   Vikman, Susanna ^a   Campos, Hannia ^b   Allayee, Hooman ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOSOLIC PHOSPHOLIPASE A2; CYTOSOLIC PHOSPHOLIPASE A2 GROUP IVA; MESSENGER RNA; OMEGA 6 FATTY ACID; POLYUNSATURATED FATTY ACID; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CARDIOVASCULAR RISK; CASE CONTROL STUDY; CONTROLLED STUDY; DIETARY INTAKE; DISEASE ASSOCIATION; FEMALE; GENE EXPRESSION; GENE INTERACTION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HEART INFARCTION; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; PHENOTYPE;

AGED; AORTA; CASE-CONTROL STUDIES; CELLS, CULTURED; COSTA RICA; DIET; ENDOTHELIUM, VASCULAR; FATTY ACIDS, OMEGA-6; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENETIC ASSOCIATION STUDIES; GROUP IV PHOSPHOLIPASES A2; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; POLYMORPHISM, SINGLE NUCLEOTIDE; QUESTIONNAIRES; RISK; RNA, MESSENGER;

EID: 84859090128     PISSN: 00029165     EISSN: 19383207     Source Type: Journal    
DOI: 10.3945/ajcn.111.032094     Document Type: Article

References (38)

1. Peters-Golden M, Henderson WR Jr. Leukotrienes. N Engl JMed 2007;357:1841-54.
2. Mehrabian M, Allayee H. 5-Lipoxygenase and atherosclerosis. Curr Opin Lipidol 2003;14:447-57. (Pubitemid 37297299)
3. Tymchuk CN, Hartiala J, Patel PI, Mehrabian M, Allayee H. Non-conventional genetic risk factors for cardiovascular disease. Curr Atheroscler Rep 2006;8:184-92. (Pubitemid 43676322)
4. Bäck M, Hansson GK. Leukotriene receptors in atherosclerosis. Ann Med 2006;38:493-502.
5. Riccioni G, Back M, Capra V. Leukotrienes and atherosclerosis. Curr Drug Targets 2010;11:882-7.
6. Mehrabian M, Allayee H, Wong J, Shi W, Wang XP, Shaposhnik Z, Funk CD, Lusis AJ. Identification of 5-lipoxygenase as a major gene contributing to atherosclerosis susceptibility in mice. Circ Res 2002; 91:120-6. (Pubitemid 34827222)
7. Mehrabian M, Allayee H, Stockton J, Lum PY, Drake TA, Castellani LW, Suh M, Armour C, Edwards S, Lamb J, et al. Integrating genotypic and expression data in a segregating mouse population to identify 5-lipoxygenase as a susceptibility gene for obesity and bone traits. Nat Genet 2005;37:1224-33. (Pubitemid 41568705)
8. Mehrabian M, Schulthess FT, Nebohacova M, Castellani LW, Zhou Z, Hartiala J, Oberholzer J, Lusis AJ, Maedler K, Allayee H. Identification of ALOX5 as a gene regulating adiposity and pancreatic function. Diabetologia 2008;51:978-88.
9. Poeckel D, Funk CD. The 5-lipoxygenase/leukotriene pathway inpreclinical models of cardiovascular disease. Cardiovasc Res 2010;86: 243-53.
10. Aiello RJ, Bourassa PA, Lindsey S, Weng W, Freeman A, Showell HJ. Leukotriene B4receptor antagonism reduces monocytic foam cells in mice. Arterioscler Thromb Vasc Biol 2002;22:443-9. (Pubitemid 34218752)
11. Subbarao K, Jala VR, Mathis S, Suttles J, Zacharias W, Ahamed J, Ali H, Tseng MT, Haribabu B. Role of leukotriene B4 receptors in the development of atherosclerosis: potential mechanisms. Arterioscler Thromb Vasc Biol 2004;24:369-75. (Pubitemid 38197592)
12. Heller EA, Liu E, Tager AM, Sinha S, Roberts JD, Koehn SL, Libby P, Aikawa ER, Chen JQ, Huang P, et al. Inhibition of atherogenesis in BLT1-deficient mice reveals a role for LTB4 and BLT1 in smooth muscle cell recruitment. Circulation 2005;112:578-86. (Pubitemid 41060799)
13. Jawien J, Gajda M, Rudling M, Mateuszuk L, Olszanecki R, Guzik TJ, Cichocki T, Chlopicki S, Korbut R. Inhibition of five lipoxygenase activating protein (FLAP) by MK-886 decreases atherosclerosis in apoE/LDLR-double knockout mice. Eur J Clin Invest 2006;36:141-6. (Pubitemid 43341263)
14. Ahluwalia N, Lin AY, Tager AM, Pruitt IE, Anderson TJ, Kristo F, Shen D, Cruz AR, Aikawa M, Luster AD, et al. Inhibited aortic aneurysm formation in BLT1-deficient mice. J Immunol 2007;179:691-7. (Pubitemid 46986588)
15. Jawien J, Gajda M, Wolkow P, Zuranska J, Olszanecki R, Korbut R. The effect of montelukast on atherogenesis in apoE/LDLR-double knockout mice. J Physiol Pharmacol 2008;59:633-9.
16. Dwyer JH, Allayee H, Dwyer KM, Fan J, Wu H, Mar R, Lusis AJ, Mehrabian M. Arachidonate 5-lipoxygenase promoter genotype, dietary arachidonic acid, and atherosclerosis. N Engl J Med 2004;350:29-37. (Pubitemid 38032181)
17. Helgadottir A, Manolescu A, Thorleifsson G, Gretarsdottir S, Jonsdottir H, Thorsteinsdottir U, Samani NJ, Gudmundsson G, Grant SF, Thorgeirsson G, et al. The gene encoding 5-lipoxygenase activating protein confers risk of myocardial infarction and stroke. Nat Genet 2004;36:233-9. (Pubitemid 38282747)
18. Helgadottir A, Manolescu A, Helgason A, Thorleifsson G, Thorsteinsdottir U, Gudbjartsson DF, Gretarsdottir S, Magnusson KP, Gudmundsson G, Hicks A, et al. Avariant of the gene encoding leukotriene A4 hydrolase confers ethnicity-specific risk of myocardial infarction. Nat Genet 2006;38:68-74. (Pubitemid 43011884)
19. Carlson CS, Heagerty PJ, Nord AS, Pritchard DK, Ranchalis J, Boguch JM, Duan H, Hatsukami TS, Schwartz SM, Rieder MJ, et al. TagSNP evaluation for the association of 42 inflammation loci and vascular disease: evidence of IL6, FGB, ALOX5, NFKBIA, and IL4R loci effects. Hum Genet 2007;121:65-75. (Pubitemid 46421142)
20. Iovannisci DM, Lammer EJ, Steiner L, Cheng S, Mahoney LT, Davis PH, Lauer RM, Burns TL. Association between aleukotriene C4 synthase gene promoter polymorphism and coronary artery calcium in young women: the Muscatine Study. Arterioscler Thromb Vasc Biol 2007;27:394-9. (Pubitemid 46150770)
21. Freiberg JJ, Tybjaerg-Hansen A, Sillesen H, Jensen GB, Nordestgaard BG. Promotor polymorphisms in leukotriene C4 synthase and risk of ischemic cerebrovascular disease. Arterioscler Thromb Vasc Biol 2008; 28:990-6. (Pubitemid 351544118)
22. Freiberg JJ, Dahl M, Tybjaerg-Hansen A, Grande P, Nordestgaard BG. Leukotriene C4synthase and ischemic cardiovascular disease and obstructive pulmonary disease in 13,000 individuals. J Mol Cell Cardiol 2009;46:579-86.
23. Crosslin DR, Shah SH, Nelson SC, Haynes CS, Connelly JJ, Gadson S, Goldschmidt-Clermont PJ, Vance JM, Rose J, Granger CB, et al. Genetic effects in the leukotriene biosynthesis pathway and association with atherosclerosis. Hum Genet 2009;125:217-29.
24. Burdon KP, Rudock ME, Lehtinen AB, Langefeld CD, Bowden DW, Register TC, Liu Y, Freedman BI, Carr JJ, Hedrick CC, et al. Human lipoxygenase pathway gene variation and association with markers of subclinical atherosclerosis in the diabetes heart study. Mediators Inflamm 2010;2010:170153.
25. Allayee H, Baylin A, Hartiala J,Wijesuriya H, Mehrabian M, Lusis AJ, Campos H. Nutrigenetic association of the 5-lipoxygenase gene with myocardial infarction. Am J Clin Nutr 2008;88:934-40.
26. Hartiala J, Li D, Conti DV, Vikman S, Patel Y, Tang WH, Brennan ML, Newman JW, Stephensen CB, Armstrong P, et al. Genetic contribution of the leukotriene pathway to coronary artery disease. Hum Genet 2011;129:617-27.
27. Kabagambe EK, Baylin A, Allan DA, Siles X, Spiegelman D, Campos H. Application of the method of triads to evaluate the performance of food frequency questionnaires and biomarkers as indicators of longterm dietary intake. Am J Epidemiol 2001;154:1126-35. (Pubitemid 33140636)
28. Livak KJ. Allelic discrimination using fluorogenic probes and the 5# nuclease assay. Genet Anal 1999;14:143-9. (Pubitemid 29095371)
29. Romanoski CE, Lee S, Kim MJ, Ingram-Drake L, Plaisier CL, Yordanova R, Tilford C, Guan B, He A, Gargalovic PS, et al. Systems genetics analysis of gene-by-environment interactions in human cells. Am J Hum Genet 2010;86:399-410.
30. Willett W. Nutritional epidemiology. 2nd ed. New York, NY: Oxford University Press, 1998.
31. Ruiz-Narváez EA, Bare L, Arellano A, Catanese J, Campos H. West African and Amerindian ancestry and risk of myocardial infarction and metabolic syndrome in the Central Valley population of Costa Rica. Hum Genet 2010;127:629-38.
32. Baylin A, Kabagambe EK, Ascherio A, Spiegelman D, Campos H. Adipose tissue alpha-linolenic acid and nonfatal acute myocardial infarction in Costa Rica. Circulation 2003;107:1586-91. (Pubitemid 36397325)
33. Alberghina M. Phospholipase A(2): new lessons from endothelial cells. Microvasc Res 2010;80:280-5.
34. Hadad N, Tuval L, Elgazar-Carmom V, Levy R. Endothelial ICAM-1 protein induction is regulated by cytosolic phospholipase A2alpha via both NF-kappaB and CREB transcription factors. J Immunol 2011;186: 1816-27.
35. Spite M, Serhan CN. Novel lipid mediators promote resolution of acute inflammation: impact of aspirin and statins. Circ Res 2010;107: 1170-84.
36. Reed KA, Tucker DE, Aloulou A, Adler D, Ghomashchi F, Gelb MH, Leslie CC, Oates JA, Boutaud O. Functional characterization of mutations in inherited human cPLA deficiency. Biochemistry 2011;50: 1731-8.
37. Thygesen K, Alpert JS, White HD, Jaffe AS, Apple FS, Galvani M, Katus HA, Newby LK, Ravkilde J, Chaitman B, et al. Universal definition of myocardial infarction. Circulation 2007;116:2634-53.
38. Schrier RW. Role of diminished renal function in cardiovascular mortality: marker or pathogenetic factor? J Am Coll Cardiol 2006; 47:1-8. (Pubitemid 43005157)